Fang Liu

Title: Innovations of Fang Liu in Collagen Active Peptides

Introduction

Fang Liu is an accomplished inventor based in Baotou, China. He has made significant contributions to the field of biotechnology, particularly in the development of collagen active peptides. His innovative methods have the potential to impact cancer treatment significantly.

Latest Patents

Fang Liu holds a patent for "Techniques of preparing collagen active peptides." This patent describes a method of preparing collagen active peptides with antiproliferative activity against cancer cells. The peptides are obtained through the hydrolysis of papain and trypsin, followed by a specific purifying process. These collagen active peptides demonstrate antiproliferative activity against various cancer cells, including ovarian carcinoma cells such as SKOV3, OVCAR3, 436, and SRO82, as well as prostate cancer cells like PC3, LnCAPC1, and LnCAPC2. He has 1 patent to his name.

Career Highlights

Fang Liu has worked with Baotou Dongbao Bio Tech Co Ltd, where he has applied his expertise in biotechnology. His work has focused on developing innovative solutions for health-related challenges, particularly in cancer treatment.

Collaborations

Fang Liu has collaborated with notable individuals in his field, including Yanchuan Guo and Bing Zhang. These collaborations have contributed to the advancement of his research and the successful development of his patented techniques.

Conclusion

Fang Liu's innovative work in preparing collagen active peptides showcases his dedication to advancing biotechnology and cancer treatment. His contributions are paving the way for new therapeutic options in the fight against cancer.